Outcome of Epstein-Barr virus-associated primary breast cancer. - Aix-Marseille Université Access content directly
Journal Articles Molecular and Clinical Oncology Year : 2015

Outcome of Epstein-Barr virus-associated primary breast cancer.

Abstract

The presence of the Epstein-Barr-virus (EBV) has been reported to be a pathogenic factor in breast cancer (BC). We previously demonstrated the aggressiveness of EBV-positive BC. The purpose of the present study was to evaluate the effect of EBV on the prognosis of BC according to the BC phenotype. A total of 117 patients with primary BC previously tested for the presence of EBV were evaluated. The presence of the virus was evaluated in breast specimens using quantitative PCR (qPCR). Disease-free survival (DFS) and overall survival (OS) were evaluated for 4 molecular subtypes, namely luminal A and B (lumA and lumB, respectively), human epidermal growth factor receptor 2 (HER2) and triple-negative (TN) subtypes and according to the EBV status. EBV positivity was observed in 32.5% of the cases. TN, HER2 and lumB tumours were more frequent among EBV-BC cases (P=0.02). The DFS rates were different between BC subtypes (P=0.002), but the differences were not statistically significant when the cases were stratified according to the EBV status (P=0.08 for EBV-negative and 0.06 for EBV-positive cases). The OS rates were similar for BC subtypes (P= 0.50) and when the cases were stratified according to the EBV status (P=0.16 and P=0.67 for EBV-positive and -negative cases, respectively). EBV was not associated with DFS or OS, in contrast to BC phenotypes, tumour size or nodal status. Therefore, EBV positivity was found to exert no effect on survival, despite its association with aggressive BC phenotypes.
Fichier principal
Vignette du fichier
mco-03-02-0295.pdf (250.12 Ko) Télécharger le fichier
Origin Publisher files allowed on an open archive
Loading...

Dates and versions

hal-01480122 , version 1 (07-03-2017)

Identifiers

Cite

C Mazouni, F Fina, S Romain, L Ouafik, P Bonnier, et al.. Outcome of Epstein-Barr virus-associated primary breast cancer.. Molecular and Clinical Oncology, 2015, 3 (2), pp.295-298. ⟨10.3892/mco.2014.459⟩. ⟨hal-01480122⟩
104 View
103 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More